Protalys Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$18.7M
- Investors
-
1
Protalys Therapeutics General Information
Description
Developer of a therapeutic delivery technology intended to improve the performance of targeted protein degradation agents. The company employs established in situ carriers to transport small-molecule degraders into solid tumors, enhancing pharmacokinetics, addressing limitations of difficult targets, enabling the rescue of previously ineffective degraders, and supporting expanded discovery opportunities in oncology.
Contact Information
Corporate Office
- San Diego, CA
- United States
Corporate Office
- San Diego, CA
- United States
Protalys Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 28-Aug-2025 | $18.7M | Completed | Startup |
Protalys Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
Protalys Therapeutics Patents
Protalys Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026136975-A1 | Albumin binder conjugated protac degraders and uses thereof | Pending | 20-Dec-2024 |
Protalys Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Avalon Bioventures | Venture Capital | Minority |
Protalys Therapeutics FAQs
-
Where is Protalys Therapeutics headquartered?
Protalys Therapeutics is headquartered in San Diego, CA.
-
What industry is Protalys Therapeutics in?
Protalys Therapeutics’s primary industry is Biotechnology.
-
Is Protalys Therapeutics a private or public company?
Protalys Therapeutics is a Private company.
-
What is the current valuation of Protalys Therapeutics?
The current valuation of Protalys Therapeutics is .
-
What is Protalys Therapeutics’s current revenue?
The current revenue for Protalys Therapeutics is .
-
How much funding has Protalys Therapeutics raised over time?
Protalys Therapeutics has raised $18.7M.
-
Who are Protalys Therapeutics’s investors?
Avalon Bioventures has invested in Protalys Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process